Real-time enrollment status for this primary central nervous system lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04947319 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Primary Central Nervous System Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 112 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Ono Pharmaceutical Co. Ltd |
| Last Updated on CT.gov | October 24, 2025 (Oct 24, 2025) |
As of March 2, 2026: Clinical trial NCT04947319 is currently active_not_recruiting participants. This clinical trial study for primary central nervous system lymphoma is not currently accepting new participants at 45 locations across the United States. The study is sponsored by Ono Pharmaceutical Co. Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04947319 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04947319 was last updated Oct 24, 2025 (October 24, 2025). HelloStudys verifies this status automatically.